BUFFALO, N.Y. – Researchers have shown for the first time that intermittent fasting increases the efficacy of anti-androgen therapy in prostate cancer, according to a paper reporting preclinical ...

Emerging evidence suggests that fasting could play a role in the fight against cancer. However, studies to date have been relatively small and results have been mixed, leaving an unclear picture of ...

Scientists based in Australia and China have identified a pair of pesky enzymes responsible for prolonging prostate cancer – ...

Prostate cancer is the most common cancer among men after skin cancer, with approximately 1 in 8 men diagnosed in their ...

PSA testing and digital rectal exams are crucial for early detection of prostate cancer, enabling timely intervention and improved outcomes. Treatment options include active surveillance, surgery, ...

An international study has uncovered a new vulnerability in prostate cancer cells that could help improve treatment for one ...

A new fast and convenient approach to scintigraphy-based monitoring allows physicians to efficiently and reliably assess ...

This comprehensive guide provides essential information to help patients and their families navigate their prostate cancer journey. Prostate cancer is a malignant tumor that develops in the prostate ...

Niraparib is a type of treatment ... that prostate cancers with alterations in HRR genes account for a significant group of ...

LOS ANGELES, July 09, 2025 (GLOBE NEWSWIRE) -- Trethera Corporation (“Trethera”), a clinical stage biopharmaceutical company developing first-in-class therapies for cancer and autoimmune diseases, ...

A new drug combo of enzalutamide and hormone therapy has been shown to extend survival for men with recurring prostate cancer, reducing death risk by over 40%. The study followed more than 1,000 ...

Biden’s personal office revealed in May that he had been diagnosed with an “aggressive form” of prostate cancer that had ...